A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. (Record no. 16306041)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01802 a2200505 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515025459.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200607s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1084-9785 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1089/cbr.2006.21.88 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wong, Jeffrey Y C |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20060718 |
| 245 00 - TITLE STATEMENT | |
| Title | A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer biotherapy & radiopharmaceuticals |
| Date of publication, distribution, etc. | Apr 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 88-100 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoembryonic Antigen |
| General subdivision | biosynthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heterocyclic Compounds, 1-Ring |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunoglobulin G |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunotoxins |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Metastasis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radioimmunotherapy |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Yttrium Radioisotopes |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chu, David Z |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Williams, Lawrence E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, An |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhan, Jiping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamauchi, Dave M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wilczynski, Sharon |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wu, Anna M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yazaki, Paul J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shively, John E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leong, Lucille |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Raubitschek, Andrew A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer biotherapy & radiopharmaceuticals |
| Related parts | vol. 21 |
| -- | no. 2 |
| -- | p. 88-100 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1089/cbr.2006.21.88">https://doi.org/10.1089/cbr.2006.21.88</a> |
| Public note | Available from publisher's website |
No items available.